Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Yumanity Therapeutics, Inc. YMTX
$1.89
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
15720642.00000000
-
week52high
3.37
-
week52low
0.95
-
Revenue
1953000
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
-4.24100000
-
Last Dividend
0.00000000
-
Next Earnings Date
22 мар 2023 г. в 04:00
Описание компании
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration. Its lead program is YTX-7739, a novel small molecule that is in Phase I clinical trial for the treatment of Parkinson's disease and related disorders of a-synuclein. The company is also developing YTX-9184, which is in preclinical studies to treat neurological disorders. Yumanity Therapeutics Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
HC Wainwright & Co. | Buy | 04 июн 2021 г. | |
Jefferies | Buy | 01 апр 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
PHILIPS CRAIG W. | A | 1382 | 1382 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 12384 | 12384 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 51600 | 51600 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 17544 | 17544 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 13760 | 13760 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 17199 | 17199 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 18919 | 18919 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 3440 | 3440 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 35088 | 35088 | 16 дек 2022 г. |
PHILIPS CRAIG W. | A | 33272 | 8658 | 16 дек 2022 г. |
Новостная лента
Why Are Chinese Stocks Up Today?
InvestorPlace
05 дек 2022 г. в 12:00
Chinese stocks are rallying on Monday as investors get more hopeful news of the country loosening its Covid-19 restrictions. Over the weekend, China reportedly let go of some of its restrictions on certain cities affected by the pandemic.
Why Is Yumanity Therapeutics (YMTX) Stock Up Today?
InvestorPlace
05 дек 2022 г. в 11:30
Yumanity Therapeutics (NASDAQ: YMTX ) stock is rocketing higher on Monday after the clinical-stage biopharmaceutical company announced a special dividend. According to a press release from the company, this special dividend will range in price from $1.34 to $1.43 per share.
Best Penny Stocks to Buy That Exploded Today? 3 to Watch
PennyStocks
06 июн 2022 г. в 16:07
Check these penny stocks out for your watchlist right now The post Best Penny Stocks to Buy That Exploded Today? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is Yumanity Therapeutics (YMTX) Stock Up 50% Today?
InvestorPlace
06 июн 2022 г. в 10:04
Yumanity Therapeutics (YMTX) stock is rocketing higher on Monday after announcing two definitive agreements. including a merger.
Yumanity Therapeutics Shares Trading Higher Today - Read Here Why
Benzinga
06 июн 2022 г. в 08:49
Yumanity Therapeutics Inc (NASDAQ: YMTX) has agreed to sell its lead clinical-stage product candidate, YTX-7739, and discovery-stage neuroscience candidates to Janssen Pharmaceutica NV, a unit of Johnson & Johnson (NYSE: JNJ) for $26 million. Yumanity plans to.